Željko Jovanović

Prof. Dr. Željko Jovanović

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2015 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
AVAleksandar Vcev
Aleksandar Vcev
DPDavorin Pezerovic
Davorin Pezerovic
ŽJŽeljko Jovanović
Željko Jovanović
DNDarko Nakic
Darko Nakic
IVIvan Vcev
Ivan Vcev
LJILJANA MAJNARICLJILJANA MAJNARIC
LJILJANA MAJNARIC

20 December 2013 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
MBM. Boban
M. Boban
VPV. Persic
V. Persic
ŽJŽeljko Jovanović
Željko Jovanović
ABA. Brozina
A. Brozina
BMBojan Miletic
Bojan Miletic
LBL. Boban
L. Boban
Obesity is a well-known risk factor in the cardiovascular disease continuum. However, its clinical effects are multimodal, perplexed and non-unanimously understood. Our aim was to assess the prevalence and effects of obesity on the cardiometabolic risk factors and systolic function of left ventricle ejection fraction (LVEF) in patients scheduled for cardiovascular rehabilitation. A cohort of 302 consecutive patients recently treated for ischaemic or valvular heart disease was matched according to the existence of obesity, defined with body mass index (BMI ≥ 30 kg/m(2) ; n = 90 vs. 212), and the advanced grade of obesity (BMI ≥ 35 kg/m(2) ; n = 19 vs. 283). Nutritional risk screening was performed using the standardised NRS-2002 tool. The mean age of patients was 62.4 ± 11.2 (range 23-86) years; there were more men than women 244 (80.8%) : 58 (19.2%). Group of obese conveyed higher prevalence of ischaemic heart disease than non-obese (OR = 2.69; 95% CI: 1.01-7.20; p = 0.048); while the difference was insignificant for the advanced grade of obesity (n = 17; 89.5%) vs. controls (n = 233; 82.3%; p > 0.05). There was no significant difference in prevalence of other comorbidities (diabetes, glucose intolerance, hypercholesterolaemia, chronic renal and chronic obstructive pulmonary disease) between studied groups (p > 0.05). Utilisation of lipid-lowering drugs was of similar range between the studied groups (p > 0.05), respectively. LVEF (%) was 50.5 ± 8.2 vs. 50.7 ± 7.7 (p > 0.05) and 50.6 ± 7.8 vs. 49.6 ± 10.9 (p > 0.05; Rho = 0.001; p > 0.05), respectively. In studied set of patients, BMI positively correlated with left ventricle dimension and thickness. No significant connection of obesity was found with the prevalence of chronic comorbidities, increased nutritional risk, laboratory diagnostics or systolic function of left ventricle. Existence of obesity paradox in clinical practice was in part reaffirmed with our study.

24 January 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ŽJŽeljko Jovanović
Željko Jovanović
PVPetra Vulić
Petra Vulić
EJEljko Jovanovi
Eljko Jovanovi
Objectives: Pregnancy is a sensitive period during which the use of medicines, whether by prescription or self-medication, is a major challenge as it can have a significant impact on the health of the mother and the development of the foetus. It is important that pregnant women are well-informed about potential risks and benefits and seek advice from healthcare professionals before taking any medication, including over-the-counter medications, to ensure the safety and health of themselves and their unborn child. The aim of this study was to analyse the self-medication practices of pregnant women and their knowledge and attitudes toward medicines in the context of pregnancy. This includes analysing the way pregnant women make decisions about self-medication and their awareness of potential risks and benefits.Methods: A cross-sectional study was conducted on a sample of pregnant women from two cities of similar size and status, Zadar and Rijeka, in the period from 1 May 2023 to 1 June 2023 at the Clinical Hospital Centre Rijeka and the General Hospital Zadar.Results: Of the 128 women interviewed, 56% were taking prescription medication, most frequently in Rijeka, while 69.5% practised self-medication. The most commonly used medications were dietary supplements—75 (44.88%); over-the-counter pain relievers and fever, cough, allergy, cold, and nausea remedies—42 (33.07%); and herbal medicines—8 (6.29%).Conclusion: Pregnant women need to be better informed about self-medication and the safe use of medication. A total of 94.5% of respondents consider it important to improve educational programmes and access to information about the effects of medication on the health of the foetus and pregnancy outcomes.

1 April 2025 in Worldviews on Evidence-Based Nursing
Verified
Journal Article
Closed access
DVDominika Vrbnjak
Dominika Vrbnjak
Dragana MilutinovićDragana Milutinović
Dragana Milutinović
MSMarija Spevan
Marija Spevan
APAgnieska Pluta
Agnieska Pluta
ŽJŽeljko Jovanović
Željko Jovanović
JNJohn W. Nelson
John W. Nelson

31 July 2014 in Journal of the American College of Nutrition
Verified
Journal Article
Closed access
MBMarko Boban
Marko Boban
ALAlessandro Laviano
Alessandro Laviano
VPViktor Persic
Viktor Persic
ARAnte Rotim
Ante Rotim
ŽJŽeljko Jovanović
Željko Jovanović
AVAleksandar Vcev
Aleksandar Vcev
The aim of our study was to assess the prevalence and characteristics of nutritional risk in patients scheduled for cardiovascular rehabilitation. Knowledge concerning nutritional aspects of cardiovascular diseases is contemporary limited. Nutritional risk screening using a standardized Nutritional Risk Screening-2002 (NRS-2002) questionnaire was performed on a cohort of consecutive patients scheduled for rehabilitation 1-6 months after treatment for ischemic, valvular, or combined causes of heart diseases. Baseline weight was available for more than 80% of patients. The study population consisted of 317 patients, aged 23-85 years, with a mean age of 62.5 ± 11.3 years. Male to female share was 253 (79.8%) and 64 (20.2%), respectively. Twenty-eight (8.8%) were treated for myocardial infarction conservatively, 151 (47.6%) by percutaneous coronary interventions, and 145 (45.7%) by surgery. NRS-2002 was 3.56 ± 1.54 in range 0-6. A high correlation was found between the NRS-2002 and percentage weight loss history (rho = 0.813; p <0.001). Significant differences according to increased nutritional risk (NRS-2002 ≥ 3) were found within age groups (p < 0.001), disease etiology (p = 0.002), cardiovascular treatments (p < 0.001), and grades of renal function (p < 0.001). Odds for developing increased nutritional risk (NRS-2002 ≥ 3) were significant for cardiovascular treatments (odds ratio [OR] = 4.35, 95% confidence interval [CI], 2.28-8.30, p < 0.001), age (OR = 3.19, 95% CI, 2.00-5.09, p < 0.001), grade of renal function (OR = 1.91, 95% CI, 1.17-3.09, p = 0.009), diabetes mellitus (OR = 2.37, 95% CI, 1.09-5.16, p = 0.029), and any psychological disturbance (OR = 2.04, 95% CI, 1.06-3.90, p = 0.032). Pronounced nutritional risk frequently existed among patients at stationary cardiovascular rehabilitation. Nutritional risk was connected with preceding cardiovascular treatments, patient age, and renal function. Further studies concerning nutritional risk and its connections with clinical outcomes might serve as a resourceful perspective to improve outcomes or quality of care for the entities from the cardiovascular diseases continuum.

1 December 2013
Verified
Journal Article
Closed access
IKIvo Klarin
Ivo Klarin
LMLjiljana Majnarić
Ljiljana Majnarić
ŽJŽeljko Jovanović
Željko Jovanović
DNDario Nakić
Dario Nakić
IVIvan Vcev
Ivan Vcev
AVAleksandar Vcev
Aleksandar Vcev